Table of Contents Author Guidelines Submit a Manuscript
Journal of Pregnancy
Volume 2014 (2014), Article ID 459192, 3 pages
http://dx.doi.org/10.1155/2014/459192
Research Article

Factor XII (Hageman) Levels in Women with Recurrent Pregnancy Loss

1Department of Obstetrics and Gynecology, Zekai Tahir Burak Women’s Health Care, Training and Research Hospital, Talatpasa Bulvari, 06230 Ankara, Turkey
2Department of Obstetrics and Gynecology, Diyarbakır Women’s Health and Children Disease Hospital, Diyarbakır, Turkey
3Department of Biochemistry, Zekai Tahir Burak Women’s Health Care, Training and Research Hospital, Talatpasa Bulvari, 06230 Ankara, Turkey

Received 31 July 2014; Revised 15 October 2014; Accepted 23 October 2014; Published 12 November 2014

Academic Editor: Antonio Farina

Copyright © 2014 A. Seval Ozgu-Erdinc et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Sugi, “Kininogen-dependent antiphosphatidylethanolamine antibodies and autoantibodies to factor XII in patients with recurrent pregnancy losses,” Journal of Obstetrics and Gynaecology Research, vol. 39, no. 7, pp. 1223–1229, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Inomo, T. Sugi, Y. Fujita, H. Matsubayashi, S.-I. Izumi, and M. Mikami, “The antigenic binding sites of autoantibodies to factor XII in patients with recurrent pregnancy losses,” Thrombosis & Haemostasis, vol. 99, no. 2, pp. 316–323, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. H.-U. Pauer, P. Burfeind, H. Köstering, G. Emons, and B. Hinney, “Factor XII deficiency is strongly associated with primary recurrent abortions,” Fertility and Sterility, vol. 80, no. 3, pp. 590–594, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. D. W. Jones, M. J. Gallimore, and M. Winter, “Antibodies to factor XII: a possible predictive marker for recurrent foetal loss,” Immunobiology, vol. 207, no. 1, pp. 43–46, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Sotiriadis, A. Makrigiannakis, T. Stefos, E. Paraskevaidis, and S. N. Kalantaridou, “Fibrinolytic defects and recurrent miscarriage: a systematic review and meta-analysis,” Obstetrics and Gynecology, vol. 109, no. 5, pp. 1146–1155, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Dendrinos, A. Deliveliotou, A. Anastasiou, and G. K. Creatsas, “Role of coagulation factor XII in unexplained recurrent abortions in the Greek population,” Journal of Reproductive Medicine, vol. 59, no. 1-2, pp. 56–62, 2014. View at Google Scholar · View at Scopus
  7. H. Yamada, E. H. Kato, G. Kobashi et al., “Recurrent pregnancy loss: etiology of thrombophilia,” Seminars in Thrombosis and Hemostasis, vol. 27, no. 2, pp. 121–129, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Yamada, E. H. Kato, Y. Ebina et al., “Factor XII deficiency in women with recurrent miscarriage,” Gynecologic and Obstetric Investigation, vol. 49, no. 2, pp. 80–83, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Matsubayashi, T. Sugi, T. Suzuki et al., “Decreased factor XII activity is associated with recurrent IVF-ET failure,” American Journal of Reproductive Immunology, vol. 59, no. 4, pp. 316–322, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Braulke, M. Pruggmayer, P. Melloh, B. Hinney, H. Kostering, and E. Gunther, “Factor XII (Hageman) deficiency in women with habitual abortion: new subpopulation of recurrent aborters?” Fertility and Sterility, vol. 59, no. 1, pp. 98–101, 1993. View at Google Scholar · View at Scopus
  11. J.-C. Gris, S. Ripart-Neveu, C. Maugard et al., “Prospective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages,” Thrombosis and Haemostasis, vol. 77, no. 6, pp. 1096–1103, 1997. View at Google Scholar · View at Scopus